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 Abstract 
 
Following the introduction of the National Health Service Breast Screening Programme 
(NHSBSP) in the UK increasing numbers of women are diagnosed with ductal 
carcinoma in situ (DCIS).  In DCIS, the cancer cells are confined to the ducts of the 
breast but considerable uncertainty surrounds the condition.  Patients are often reassured 
that it is non-invasive and not life-threatening but they are recommended similar 
treatments to patients with invasive breast cancer.  Little research has investigated the 
psychosocial impact of DCIS; therefore the aim of this qualitative study was to explore 
women’s experiences of the condition.  Semi-structured interviews were conducted with 
a purposive sample of 16 women previously diagnosed and treated for DCIS.  Thematic 
analysis identified six key themes: 1) Invisibility of DCIS, 2) Uncertainty, 3) 
Perceptions of DCIS, 4) Acceptance of Treatment, 5) Social Support and 6) Moving On.  
The results highlight the substantial challenges faced by women diagnosed with DCIS.  
These findings have clear significance for healthcare professionals, especially specialist 
nurses, who work closely with DCIS patients. 
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Introduction 
 
Since the NHS Breast Screening Programme was established the rates of diagnosis of 
ductal carcinoma in situ (DCIS) have increased dramatically and now represent 20% of 
screen-detected cancers in the UK (NHSBSP, 2006).  DCIS is a non-invasive breast 
condition where cancer cells are confined to the ducts of the breast (Leonard and Swain, 
2004).  Following treatment most patients have an excellent prognosis and few will 
ultimately die of breast cancer (Ernster et al. 2000).  
However, although a diagnosis of DCIS is not indicative of a life-threatening 
condition, this does not necessarily imply that patients endure less psychological 
distress.  Instead, ‘different’ psychosocial problems may occur (Wellisch, 1997) which 
may be due to a number of issues.  Firstly, as DCIS is commonly detected 
asymptomatically it is often unanticipated (Hamilton, 1992) and the majority of women 
are unaware that the condition exists (Schwartz et al., 2000; Prinjha et al., 2006).  The 
natural history of DCIS remains poorly understood because most patients receive 
surgery (Erbas et al., 2006); currently therefore it is difficult to accurately predict the 
risk of developing invasive breast cancer with or without treatment.  Treatment options 
for DCIS are also controversial but involve surgery, possibly radiotherapy and hormone 
therapy.  Therefore, ironically patients may be reassured that the condition is non-
invasive and not life-threatening yet the treatment offered is similar to invasive breast 
cancer (Webb and Koch, 1997). 
In contrast to invasive breast cancer, there is scarce psychosocial research 
specifically focusing on DCIS (Carrera and Payne, 1999).  Anecdotal reports propose 
that the favourable prognosis should result in lower levels of psychosocial concerns 
(Hoffman, 1997).  However, Rakovitch et al. (2003) found that despite the generally 
positive outlook, DCIS patients expressed serious concerns and similar psychological 
morbidity to patients with invasive breast cancer.  Research also suggests that women 
are confused about DCIS (De Morgan et al., 2002), have deficient knowledge about the 
condition and worry about their future cancer risk (Bluman et al., 2001).   
 
Aim 
 
The small number of previous studies highlights the limited understanding of the 
psychosocial impact of DCIS.  Therefore, a qualitative exploratory study with patients 
previously diagnosed with DCIS was designed, with the aim of investigating women’s 
experiences of the condition, in order to inform the provision of appropriate support and 
future research. 
 
 
Methods 
 
Design 
A qualitative approach was employed because of the exploratory nature of the study and 
the lack of existing research in the area.  The use of a qualitative approach is endorsed 
by Carrera and Payne (1999) who recognise its value and appropriateness in enabling a 
detailed understanding of DCIS.  Qualitative interviews are also encouraged when 
researching sensitive areas such as this, because they allow participants to describe and 
validate their experience (Mathieson, 1999).  The key objective of the study was to gain 
an in-depth account of women’s experiences of DCIS, thus exploring their ‘lived 
experiences’ of the condition and following a phenomenological approach which 
maintains that each person has a unique view which is meaningful and valid (Streubert 
and Carpenter, 1995).  Furthermore, this approach was considered important prior to 
embarking on more detailed studies (see conclusion section for further details). 
 
Recruitment 
Women who had previously been diagnosed with DCIS were recruited through various 
media, including adverts on the websites and newsletters of relevant support 
organisations (Breast Cancer Campaign and Breast Cancer Care).  Interested volunteers 
contacted the researcher (first author) for further information.  The inclusion criterion 
was women who reported a diagnosis of DCIS in the UK within the last 10 years but 
were at least 6 months post-diagnosis.  Non-UK patients and those diagnosed over 10 
years previously were excluded because clinical policies and treatment protocols may 
differ (between countries and over time).  As the study was exploratory and 
retrospective, to have included women less than 6 months post-diagnosis may have 
reduced their ability to reflect on the whole experience.   Furthermore, the final 
selection of interviewees were selected using purposive sampling to reflect the diversity 
of detection and treatment experiences within DCIS, thus aspires to the qualitative 
paradigm (Barbour, 2001). 
 
Participants  
16 women participated in the study.  The majority were married (n = 11) and ranged 
between 39 and 74 years of age (average age 52.5 years).  Average time since diagnosis 
was 41 months (ranging from 8 to 108 months).  Seven participants were diagnosed 
asymptomatically by routine screening, seven found a lump or symptom (e.g. pain) and 
for two it was an incidental finding during clinical investigation of the contra-lateral 
breast.  Participants had been treated in a number of hospitals across the UK.  Several 
had undergone multiple procedures, but the final treatments were mastectomy (n = 4), 
mastectomy with reconstruction (n = 6; 5 immediate, 1 delayed) and wide local excision 
(WLE) or lumpectomy (n = 6; 2 with radiotherapy).   
 
Interviews 
Semi-structured interviews were conducted in participants’ homes by the first author 
who had previous experience of conducting qualitative interviews with oncology 
patients.  The interviews lasted an average of 50 minutes.  An interview schedule 
developed from previous research (De Morgan et al., 2002; Carrera, 2000; Mathieson 
and Stam, 1995) guided the interviews.  The acceptability and suitability of the schedule 
was established by two key informants who had previously been treated for DCIS.  The 
areas explored included the experience of diagnosis, treatment, decision-making, 
information and care.  Topics were deliberately kept broad to allow women to tell their 
own stories.  Further detail of the schedule is available from the first author.   
 
Ethics 
Ethical approval for this study was achieved from the university ethics committee.  
Participation in the study was voluntarily and a written informed consent was obtained 
from participants prior to the interview, and their right to withdraw from the study, at 
any time, was highlighted. 
 Rigor 
To enhance the validity of the study findings a number of techniques were used 
(Barbour, 2001).  Analysis was primarily carried out by the lead author, however, a 
random selection of the transcripts were additionally coded (by three independent 
researchers and the second author) in order to verify the analysis.  This revealed similar 
codes and themes.  A summary of the study themes was also sent to participants for 
member checking.   
 
 
Data analysis 
 
The data was transcribed verbatim and analysed with inductive thematic analysis using 
the guidelines specified by Braun and Clarke (2006).  This method uses a systematic 
and transparent process to identify, analyse and report patterns within the data 
(Boyatzis, 1998; Braun and Clarke, 2006).  This involved reading and rereading the 
transcripts, noting and formulating codes into emergent major themes.  This technique 
was suitable due to the lack of existing research and enabled a rich account of the 
experience of DCIS.   
 
 
Findings 
 
Six key themes were identified in the analysis: 1) Invisibility of DCIS, 2) Uncertainty, 
3) Perceptions of DCIS, 4) Acceptance of treatment, 5) Social support, and 6) Moving 
on.  These will be discussed using exemplars from the interviews.  To maintain 
anonymity all identifying features have been removed and pseudonyms are used 
throughout. 
 
    
Invisibility of DCIS 
 
Reactions to the diagnosis primarily entailed shock and distress.  This was shared by all 
the women, but appeared especially prominent in asymptomatic patients:   
 
if you find a lump…in the days or weeks between finding the lump and getting 
in front of a surgeon you’ve had all sorts of things going through your head and 
you’re vaguely prepared (‘Sue’, aged 46) 
 
Most women initially expressed indifference when they were recalled for further tests or 
at the first sign of a problem.  Therefore most were ill-prepared, the diagnosis was 
unexpected and the shock was enhanced by the invisibility of DCIS and because they 
felt fit and healthy, not ill.  Several women were shown the area of concern on the 
mammogram and some requested a copy of their pathology report, which helped them 
to visualise the DCIS: 
 
I did ask about getting pathology reports…it’s almost like a physical thing to 
look at, to take in what’s been invisible (‘Lisa’, aged 49) 
 
Some women described being ignorant about the possible outcomes of screening and 
others claimed that the information supplied before breast screening should mention the 
possibility of DCIS being discovered.  Thus, the invisibility of DCIS extends beyond 
the lack of physical symptoms and relates to a lack of awareness both individually and 
universally of the condition, especially within the screening service: 
 
breast screening literature really ought to make it clear; women…don’t know 
about DCIS…we need to know before that so that we’re prepared (‘Denise’, 
aged 55) 
 
The majority of women had never heard of the condition prior to their diagnosis - only 
one participant had been aware of it.  Even among those who had symptoms, the 
diagnosis of DCIS was still foreign to them.  It is possible that the invisibility of DCIS 
intensified the shock and distress experienced.   
  
Uncertainty 
 
Uncertainty resonates throughout the women’s accounts of condition itself and the 
information available.   
The terms used to depict the condition varied considerably but included ‘breast 
cancer’, ‘early cancer’, ‘in situ’, ‘pre-malignant’, ‘ductal carcinoma in situ’, ‘DCIS’, 
‘abnormal cells’, ‘non-invasive’ and ‘pre-cancer(ous)’.  This reveals the diverse 
language used by different healthcare professionals and in the information literature.  
One woman who had several second opinions said: 
 
I’ve found that each hospital does have…different terms for it (‘Nicola’, aged 
41) 
 
This contributed to confusion, uncertainty and difficulty understanding the diagnosis: 
 
I was having serious trouble, as I was discovering more about DCIS, about what 
it meant, whether it was really cancer…why I had to…loose my whole breast 
(‘Mary’, aged 74) 
 
Women also recognised the uncertainty that their diagnosis was ‘only’ DCIS since there 
was still a possibility of invasive cancer being identified: 
 
relieved that they don't think it's invasive, but it might be. They won't know 
actually until they do the surgery, so that sword is still hanging over your head 
(‘Mary’, aged 74) 
 
Unfortunately the information provided did not alleviate this uncertainty.  Although 
most women reported receiving basic information about DCIS, this was often limited to 
the first consultation or one leaflet amongst others that focused primarily on invasive 
breast cancer.  Most women emphasised that information was absent, limited or 
contradictory, thus leaving them with further ambiguity: 
 
something in the literature that you read is…‘women are confused about DCIS’ 
and that makes me terribly angry, we’re not confused…we’re given confusing 
information…the information isn’t there or seems contradictory (‘Denise’, aged 
55) 
 
Some women acknowledged the lack of scientific evidence, especially about the 
invasive potential of DCIS, which was a great concern.  Uncertainty was also evident in 
reports of discrepant treatment advice from different professionals:  
 
having thought I needed radiotherapy all the way through, to then having this 
blip where I thought maybe I didn’t (‘Lisa’, aged 49) 
 
This inconsistent and often scarce information fuelled the women’s confusion and 
desire to undertake independent research into the condition.  Most expressed this need, 
the majority in response to the unfamiliarity and uncertainty surrounding DCIS.  
Women searched extensively for information from experts, the internet, journals and 
books.  This process was described as empowering, and was seen as essential to make 
informed decisions and understand the necessity of the treatment.  However, even 
following this research a number of women acknowledged that the answers to some of 
their questions remained unknown:  
 
the question that somebody diagnosed with DCIS wants to know…what are the 
risks of this, for me, turning into invasive cancer? And we’ve got no information 
to give them, why, because as soon as anybody’s diagnosed with this it’s cut 
away (‘Mary’, aged 74) 
 
However, women also acknowledged the difficulty in providing the right balance of 
information to meet individual needs.  Suggestions were made about giving basic details 
and directing patients towards approved websites, books or articles.  Above all, 
receiving honest information about DCIS was emphasised, including recognition of the 
current uncertainties. 
 
Perceptions of DCIS – ‘Breast cancer or not?’ 
 
Several perceptions of DCIS emerged across the interviews, specifically whether 
women viewed the condition as breast cancer or not.  This related to attitudes towards 
treatment, decision-making and support.  The theme also extends to the reactions and 
attitudes of those surrounding the patient, thus where relevant, the women’s comments 
about others’ views of DCIS are included in this theme. 
 
Breast cancer 
A number of women described how they simply saw their diagnosis as ‘breast cancer’, 
but perhaps emphasised that it was a different or lesser type of the disease:  
 
as far as I was concerned it was just a different sort of breast cancer (‘Carol’, 
aged 50) 
  
Given that many of the women were given little specific information about DCIS and it 
was often included alongside general breast cancer literature it is not surprising that they 
expressed this view of their diagnosis.  These women frequently felt relieved that their 
condition was detected at an early stage.  Some participants indicated the importance of 
breast screening and others were thankful that they had followed their instincts about 
their symptoms.  These appraisals indicate further their view of the condition as breast 
cancer, and most of these women readily accepted the treatment offered. 
DCIS was generally viewed by family and friends as ‘breast cancer’, as they 
tended to focus on the treatment offered.  This may reflect the lack of awareness and the 
complexity of DCIS for others: 
 
There’s very little information in the public domain…we need our own Kylie, to 
have a DCIS, to say I’ve had DCIS so people become more aware (‘Kate’, aged 
50) 
 
Not ‘real’ breast cancer 
Other women maintained that DCIS was ‘not real breast cancer’, rather it was:  
 
this mismatch…you fall between normal and cancer (‘Kate’, aged 50)  
 
These women often acknowledged the possibility that the DCIS could develop into 
‘real’ breast cancer in the future and they considered this risk to be a strong reason to 
undergo treatment, almost as a preventative action.  However, this perception 
sometimes impacted on the women’s feelings towards their diagnosis.  Two women 
described the conflict within themselves in their reaction to something that was not 
‘real’ cancer:  
 
one of the things I felt was guilt…because I was reacting emotionally in a way 
that I thought was disproportional to something that was nothing (‘Kate’, aged 
50) 
 
Women openly compared themselves to patients with invasive breast cancer, in that 
they had endured similar surgery and expressed how they also needed support.  
However, despite this, some felt that they, unlike those with invasive disease, were not 
entitled to use resources or request staff time because they didn’t have ‘real’ cancer:  
 
I wasn’t…ill enough to be using the hospice resources…one of the women had 
had exactly the same treatment as me but she’d had invasive cancer (‘Lisa’, aged 
49) 
 
Furthermore, one participant reported her worry of how to describe the condition to 
others: 
 
whether you say you’ve had breast cancer or not, because technically I 
haven’t… because it wasn’t invasive…it’s daft to say ‘well I haven’t had breast 
cancer but I’ve had a mastectomy anyway’ (‘Denise’, aged 55) 
 
Pre-cancer 
Finally, three participants emphatically conveyed that: 
 
it isn’t cancer, its pre-cancer (‘Jacky’, aged 45) 
 
This view often reflected what they had read about DCIS or the description they had 
been given by health professionals.  These women often stressed the uncertainty about 
the risk in an optimistic way, for example that it may never develop into invasive 
cancer: 
 
I latched on to it in a ‘yeah but it might not way’ rather than, another woman 
might think ‘what do you mean it could…bloody hell I’ll get rid of this 
now’...my mind just went the other way (‘Nicola’, aged 41)  
 
However, this perception created specific difficulties when a mastectomy was advised: 
 
we saw a doctor who said ‘you don’t have breast cancer’…‘but we’re going to 
offer you a mastectomy’. And that really seemed a paradox (‘Denise’, aged 55) 
 
This links to the women’s belief that treatment is paradoxical (see next theme: 
“Acceptance of Treatment”): 
 
Contrasting perceptions 
Participants reported considerable variation in how health professionals viewed and 
described the condition, but one of the strongest feelings that emerged was that, at 
times, the medical staff treated their diagnosis as inferior:  
 
it’s not exactly that you’re a second class citizen but…I don’t think you’re 
afforded the same concern  (‘Sue’, aged 46)  
 
An underlying feeling expressed by several women was that because they ‘only’ had 
DCIS, they were ‘lucky’.  However, some challenged this because, like those with 
invasive disease, they had undergone extensive treatment: 
 
a lot of us are told when we are diagnosed with DCIS…that we are lucky.  
We’re very fortunate…when you are feeling absolutely depressed like you’ve 
been hit with a sledgehammer…you should feel lucky, when you don’t (‘Mary’, 
aged 74) 
 
This trivialisation was generally described as unfair and unhelpful.  Most women 
accepted that DCIS was not as serious as invasive breast cancer but, to them, it was still 
a difficult, uncertain time and they needed sensitivity and support from the healthcare 
professionals: 
 alright it’s not full blown stage four breast cancer, but to every woman who 
hears a diagnosis like that it might as well be…we all need them (‘Kathy’, aged 
50) 
 
One participant described that this made it difficult for her to seek much needed 
support:  
 
might be only DCIS but look what you’ve done to me…it made it difficult…to 
seek after the right support because you kind of felt that women with ‘real’ 
breast cancer should get that…was difficult, you kind of just shut up and got on 
(‘Sue’, aged 46) 
 
However, equally distressing for two women were the medics who curtly regarded their 
DCIS as ‘breast cancer’.  Interestingly this contradicted the women’s own perception 
that it was pre-cancer, and this conflict may have prompted their dissatisfaction:  
 
I can’t see why if this isn’t breast cancer…, I need a mastectomy…she [nurse] 
was very brusque ‘you just see it as a tumour…it has to go’ (‘Denise’, aged 55) 
 
Therefore, it appears that difficulties arose when a mismatch was present between the 
women’s perception of the condition and how others, particularly health professionals, 
viewed DCIS and interacted with them. 
 
Acceptance of Treatment 
 
Acceptance of treatment appeared to be strongly linked to the women’s perception of 
DCIS and the uncertainty surrounding the condition.  This can be conceptualised along 
a continuum; at one extreme some were reluctant to undergo surgery and stressed the 
paradox this presented; whereas others readily accepted the treatment. 
 
Paradox 
The conflict between the favourable prognosis of DCIS and the recommended surgery 
was highlighted.  This paradox was predominantly upheld by those who perceived it as 
a pre-cancer (links with previous theme “Perceptions of DCIS”) and were offered a 
mastectomy: 
 
I very probably only had…pre-cancer and yet they want to treat it more 
surgically, more radically than, it just doesn’t seem to make sense to me 
(‘Nicola’, aged 41) 
 
A few women further emphasised this irony when comparing themselves to patients 
with invasive disease who sometimes had less extensive surgery.  Accusations of 
overtreatment were expressed by some alongside emphasis of the medical uncertainty.  
This conveyed a strong sense of distrust in the health professionals and medical world: 
  
they’ve got a technology which identifies changes in cells which might be 
something and therefore they have to give you the worst of the 
treatment…because they don’t know what else to do (‘Mary’, aged 74) 
 
One woman described that she still finds herself questioning the mastectomy she 
underwent (now almost 2.5 years post-treatment):  
 
I can’t reconcile the two things, I am grateful not to have breast cancer…but 
somewhere deep inside I don’t understand why I had to have that operation 
(‘Denise’, aged 55)  
 
Interestingly, four participants delayed their treatment while they researched the 
condition.  All of these women emphasised the paradox, three strongly argued that 
DCIS is pre-cancer and that they were willing to take the risk.  After much deliberation, 
and often turmoil, most accepted the treatment.  One developed an invasive cancer and 
others realised they could not live with any continued uncertainty.  However, these 
women often felt “railroaded” into the system and expressed that the initial urgency to 
undergo treatment was unnecessary due to the early stage of DCIS. 
 
Acceptance 
In contrast, some women readily accepted the treatment.  The perceived risk was often 
the main focus for these women: 
  
‘if there is anything there, I don’t want it there...get rid of it (‘Ellie’, aged 39) 
 Furthermore, unlike the previous group, although uncertainty was prominent it was 
viewed more pessimistically.  Some recognised the possibility that an invasive cancer 
might be detected during the surgery to remove the DCIS and most could not accept the 
implications of declining treatment:  
 
If I didn’t have any treatment…I was going to live with the uncertainty 
(‘Emma’, aged 59) 
 
Most women pursued and trusted the surgeon’s advice, although two participants chose 
a mastectomy which was not initially suggested.  Other decisions reflected fears 
concerning the toxicity of radiotherapy and the availability of reconstruction after 
mastectomy.  
 
Social Support 
 
Many women described positive care and support received from health professionals:  
 
I was treated with enormous compassion and respect at every point…I felt I was 
very much part of the process (‘Emma’, aged 59) 
 
However, some had mixed experiences and a few endured difficulties with at least one 
member of their medical team.  Some felt that the professionals were solely focused on 
medical issues which left them feeling unsupported in relation to emotional needs: 
  
The minute I shed a tear he [surgeon] was out of the door…he was very 
detached from the emotional side (‘Carol’, aged 50) 
 
As previously discussed many indicated they felt their diagnosis was treated trivially, 
and this prompted some to feel excluded from the support services: 
 
I didn’t feel like I…was entitled to have that breast care nurse really, although 
she was assigned to me (‘Lisa’, aged 49) 
 
Women frequently described the shock and distress of the diagnosis for their family, 
which was often linked to others viewing DCIS as breast cancer and therefore support 
was given accordingly:  
 
everyone else was afraid then that I was going to die of cancer…because nobody 
knew what the DCIS was (‘Jane’, aged 52) 
 
This social support helped most to cope; however a few described the negative 
implication of others viewing their diagnosis as breast cancer.  Some found it difficult to 
talk about their diagnosis, and one woman recounted that the kind support she had 
received from others made her feel guilty: 
 
a fraud…people know you’ve got this breast cancer diagnosis and they are all 
concerned as they would be if you had ‘real’ breast cancer (‘Mary’, aged 74) 
 Many participants felt that peer support could have been improved; especially contact 
with other DCIS patients:  
 
I never, never saw face-to-face anybody who’d ever had DCIS, which was a 
disaster because that was who I needed to talk to (‘Mary’, aged 74) 
 
This was portrayed as being in contrast to the availability of breast cancer networks.  
‘Mary’ was later involved in encouraging the inclusion of DCIS in various support 
websites (Breast Cancer Care; DIPEx).  These recent developments of DCIS specific 
support were acknowledged favourably by other participants:  
 
get on the website…it was my bible going on there…anytime of the day or night 
and someone’s always there to give you…push you along (‘Ellie’, aged 39) 
 
A few women found it helpful to speak with patients with invasive cancer or attend 
breast cancer support groups.  However, others felt the issues were very different and 
reported the difficulty of discussing DCIS with patients with invasive disease:  
  
I’ve contacted a number of DCIS patients who, like me, find it really quite 
difficult to discuss breast cancer with women who’ve had other breast cancer 
diagnoses and not DCIS (‘Mary’, aged 74) 
 
This highlights that the women viewed themselves as different to patients with invasive 
disease and most emphatically agreed that being able to share their feelings in DCIS 
specific support groups would have helped reduce the isolation of this diagnosis. 
 
‘Moving on’ following DCIS 
 
Although some participants appeared to have adjusted well, others expressed concern 
relating to the ongoing implications of their DCIS diagnosis.  These concerns are 
categorised as psychological, physical and attitudes towards breast screening. 
 
Psychological 
Women talked vividly about the initial period of shock being a surreal time and some 
experienced feelings of denial at this stage.  Many stressed it was not easy to forget, 
some were prescribed anti-depressants or counselling and most spent a considerable 
time afterwards reflecting and trying to move on.  
Likewise, anxiety about recurrence was frequent and continued long after the 
treatment had ended:  
 
it never leaves you…four years on I still think oh god…is that something 
(‘Ellie’, aged 39) 
 
Changes in identity, both positive and negative, were also evident.  Some spoke avidly 
about positive changes in attitude, increased empathy and personal strength; however 
others disclosed lingering feelings of self-doubt and reduced self-confidence: 
 I’m a more anxious person now, so I think somewhere in the whole process I 
have changed. Part of it might just be that it pricked my little bubble of 
invulnerability (‘Denise’, aged 55) 
 
Finally, some expressed that the diagnosis had forced them into a medical category that 
subsequently informed health choices and affected interactions with medical staff.   
 
Physical 
Appearance concerns were evident for several women across surgical categories.  
Although some were pleased with the end result; others were very conscious about their 
appearance: 
 
I can’t wear the sort of the bras I used to wear and that’s something I do feel 
quite sad about because…my body doesn’t feel quite the same now (‘Lisa’, aged 
49) 
 
Physical problems were also described, primarily among mastectomy patients, including 
difficulties with prostheses, stiffness, pain and discomfort:  
 
the repercussions of that diagnosis have been immense on my life because I 
feel… physically disabled in a lot of ways, there are a lot of things I can’t do 
now (‘Jacky’, aged 45) 
 
Attitudes towards breast screening 
For some women the experience had undoubtedly influenced their feelings towards 
breast screening.  Some endorsed the importance of screening because it detects 
abnormalities early.  However, scepticism and negativity were also evident.  One 
woman described how the disillusionment has prompted her to decline any future 
appointments, she explains: 
 
I’ve taken a shot in the dark…why do I want to go to be told that I’ve got white 
spots on my breast, when all I know about these white spots…it’s so uncertain 
and making you ill when you're probably not ill, that I don’t want to put myself 
through that again (‘Mary’, aged 74) 
 
 
Discussion and implications for nursing 
 
The six themes in this study primarily suggest that DCIS is a challenging diagnosis.  In 
spite of the relatively good prognosis, women’s accounts reveal that for some, the 
experience is distressing and the implications are long-term, resulting in personal 
difficulties ‘moving on’ from the experience.  The findings support the growing 
evidence that DCIS patients do not face ‘less’ distress (Rakovitch et al., 2003) but 
encounter different stress and emotions compared with those diagnosed with invasive 
breast cancer (Wellisch, 1997).  This study identified a number of key issues which 
should be recognised and could inform future care and support in order to help DCIS 
patients adjust following the diagnosis and treatment. 
Many of the difficulties reported reflect the considerable uncertainty 
surrounding the condition.  In addition to the absence of prior awareness of DCIS, the 
uncertainty and lack of specific information created much confusion and distress.  
Similar findings have been reported by De Morgan et al. (2002) and Bluman et al. 
(2001).  Therefore it seems justified, and in line with previous commentary (Thornton, 
1997), that raising awareness of DCIS in general and particularly before screening 
should be carefully considered so that women are more prepared and aware of the 
condition. 
It is widely accepted that most women with invasive breast cancer require 
adequate information to help them accept and adjust to the diagnosis (Graydon et al., 
1997) and this can enhance psychological well-being (Okamura et al., 2003).  This 
study suggests that DCIS patients have similar needs, requiring accurate and sufficient 
information to facilitate adjustment, but importantly in the case of DCIS, information is 
needed particularly to achieve an understanding of an unfamiliar and complex 
condition.  The lack of clear information prompted many women to search 
independently; hence there is a need to determine the best way to provide reliable and 
adequate information to patients in light of the current ambiguities.  In Australia, the 
National Breast Cancer Centre (NBCC) has produced a comprehensive publication 
specifically about DCIS (NBCC, 2004) and similar possibilities in the UK and 
elsewhere in Europe should be explored. 
Women in the study held diverse perceptions about the condition (De Morgan et 
al., 2002) that appeared to have an impact on their adjustment; especially feelings 
towards treatment, interactions with health professionals, information and support.  The 
findings imply that perceptions of DCIS could influence acceptance, and previous 
research suggests that inaccurate perceptions can increase psychosocial distress (Buick, 
1997; Cameron and Moss Morris, 2004).  Leventhal et al. (1980) proposed that illness 
perceptions develop from a variety of sources, such as the treatment, communication, 
information and past illness experiences.  Their views seem very relevant to DCIS. 
In the context of clinical practice it may be beneficial for health professionals to 
explore how patients perceive DCIS.  This could help to identify those individuals who 
require more support and resources could be tailored accordingly.  For example, a 
patient who views DCIS as ‘not breast cancer’ may require more time and guidance to 
understand the condition and treatment options.  It is also imperative that caution is 
exercised in how DCIS is described and that the terminology used by different sources 
(e.g. health professionals, clinic and wider literature) is consistent to help reduce some 
of the confusion that can accompany the diagnosis (Fallowfield, 2007).   
The significance of appropriate support and sensitivity from the healthcare staff 
involved with DCIS patients is crucial.  This is especially important due to the 
unfamiliarity and uncertainty of DCIS and patients may require more assistance in order 
to understand and accept the condition.  Reassurance and positivity is beneficial because 
patients should recognise that the outlook for DCIS is favourable (Hoffman, 1997; 
Brown et al., 2000) but the women in this study emphasised that they still needed 
support and this should be recognised.  It is evident that any mismatch between the 
patient and health professional views is undesirable.  This was also highlighted by 
Bluman et al. (2001) and previous research indicates that this may be detrimental to 
doctor-patient relationships and a barrier to effective communication (Buick, 1997; 
Heijmans et al., 2001).  The present findings suggest that these sorts of conflict were a 
source of considerable distress for some women. 
Finally, the value of peer support is emphasised by this study.  Some women 
found contact with patients with invasive disease was beneficial (Brown et al., 2000); 
whereas others noted that support from other DCIS patients would be more valuable 
(alike De Morgan et al., 2002).  It cannot be assumed that the similarities in treatment 
will bond these two groups and this study indicates that DCIS patients can be conscious 
of the differences.  In terms of clinical practice, specifically tailoring support resources 
for DCIS may be favourable and would be readily accepted by those affected.  
 
Limitations 
While the current study provides some important insights into the experience of being 
diagnosed with DCIS, several limitations are evident.  Firstly, all the women self-
selected and self-reported a previous DCIS diagnosis, thus volunteer bias may be 
present and the participants may differ to non-responders.  Although participants were 
carefully selected on the basis of the medical details they disclosed, without accessing 
the women’s medical records the diagnosis of DCIS cannot be definitively verified.  It 
is therefore acknowledged that the results may not be representative of all DCIS 
patients.    
 
 
Conclusions 
 
DCIS presents an unfamiliar and uncertain condition that can be a challenging diagnosis 
for those affected.  The areas explored in this paper highlight a number of key issues 
and emphasise the need for further research to explore the psychosocial impact of DCIS.  
In particular, future research should involve prospective, longitudinal studies following 
DCIS patients from the time of diagnosis (which is currently being undertaken and 
further details are available from the first author), in order to more fully inform future 
patient care and support services.   
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